We are pleased to announce that Paul LaViolette, Managing Partner, COO, SV Health Investors, and seasoned medical technology executive, will be joining us as a Keynote Speaker on our DUBLIN 2018 conference program, on Tuesday, April 17th.
LaViolette, with over 35 years of global medical technology management experience, joined SV in 2009 as a Venture Partner and in 2011 was made a Partner. Paul was promoted to Managing Partner & COO in 2014 and heads medical device investments.
LaViolette built and ran medical device businesses for 29 years before joining SV Health Investors. Most recently he was COO at Boston Scientific (BSC), an $8 billion medical device leader. During his 15 years at BSC, Paul served as Chief Operating Officer; Group President, Cardiovascular; President, Cardiology; Group President, Endosurgery; and President, International. During his tenure, the company grew revenue over 20 times. Paul integrated two dozen acquisitions and led extensive product development, manufacturing and worldwide commercial organizations.
April 17-19, 2018
The Shelbourne Hotel, Dublin
27 St. Stephen’s Green, Dublin 2, Ireland
Our Annual Dublin Conference is Considered the Preeminent Medtech Investment Event in Europe
This exceptional investment and networking event – recognized by the medical device industry as the leading medical technology investment forum in Europe – will take place April 17th through 19th, 2018, once again at the historic and centrally located Shelbourne Hotel, Dublin, overlooking St. Stephen’s Green. DUBLIN 2018 is being hosted by MedTech Strategist.